Cargando…

Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB

Monoclonal antibodies against immune checkpoint blockade have proven to be a major success in the treatment of melanoma. The programmed death receptor-1 ligand-1 (PD-L1) expression on melanoma cells is believed to have an inhibitory effect on T cell responses and to be an important escape mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gowrishankar, Kavitha, Gunatilake, Dilini, Gallagher, Stuart J., Tiffen, Jessamy, Rizos, Helen, Hersey, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386825/ https://www.ncbi.nlm.nih.gov/pubmed/25844720 http://dx.doi.org/10.1371/journal.pone.0123410

Ejemplares similares

Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma
por: Chatterjee, Aniruddha, et al.
Publicado: (2018)

Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
por: Gallagher, Stuart J, et al.
Publicado: (2015)

Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling
por: Heinemann, Anja, et al.
Publicado: (2015)

Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes
por: Tiffen, Jessamy C., et al.
Publicado: (2015)

Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma
por: Tiffen, Jessamy, et al.
Publicado: (2016)

Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
por: Punnia-Moorthy, Gaya, et al.
Publicado: (2021)

Sex bias of females in survival from cancer and infections. Is X the answer?
por: Emran, Abdullah Al, et al.
Publicado: (2021)

Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?
por: Emran, Abdullah Al, et al.
Publicado: (2020)

Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
por: Emran, Abdullah Al, et al.
Publicado: (2020)

Nicotinamide Inhibits T Cell Exhaustion and Increases Differentiation of CD8 Effector T Cells
por: Alavi, Sara, et al.
Publicado: (2022)

Transcriptional Reprogramming and Constitutive PD-L1 Expression in Melanoma Are Associated with Dedifferentiation and Activation of Interferon and Tumour Necrosis Factor Signalling Pathways
por: Ahn, Antonio, et al.
Publicado: (2021)

Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients
por: Pirozyan, Mehdi R., et al.
Publicado: (2020)

Regulation of PD-L1 Expression by NF-κB in Cancer
por: Antonangeli, Fabrizio, et al.
Publicado: (2020)

Targeting constitutive NF-κB specifically in tumor cells
por: Jeong, Ji-Hak, et al.
Publicado: (2017)

17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines
por: Hartman, Mariusz L., et al.
Publicado: (2020)

PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway
por: Mirzaei, Reza, et al.
Publicado: (2021)

A homeostatic model of IκB metabolism to control constitutive NF-κB activity
por: O'Dea, Ellen L, et al.
Publicado: (2007)

Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor
por: Nishio, H, et al.
Publicado: (2014)

GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors
por: Fu, Yujie, et al.
Publicado: (2020)

PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium
por: Dowell, Alexander C., et al.
Publicado: (2021)

Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy
por: Shklovskaya, Elena, et al.
Publicado: (2020)

Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients.
por: Murray, E., et al.
Publicado: (1977)

NF-κB as potential target in the treatment of melanoma
por: Madonna, Gabriele, et al.
Publicado: (2012)

Desmoplastic melanoma: C>Ts and NF‐κB
por: Rabbie, Roy, et al.
Publicado: (2016)

Influence of Caloric Restriction on Constitutive Expression of NF-κB in an Experimental Mouse Astrocytoma
por: Mulrooney, Tiernan J., et al.
Publicado: (2011)

Constitutive Activation of IKK2/NF-κB Impairs Osteogenesis and Skeletal Development
por: Swarnkar, Gaurav, et al.
Publicado: (2014)

Luciferase expression and bioluminescence does not affect tumor cell growth in vitro or in vivo
por: Tiffen, Jessamy C, et al.
Publicado: (2010)

PD-L1 Expression Is Regulated By NF-κB During EMT Signaling In Gastric Carcinoma
por: Xu, Dan, et al.
Publicado: (2019)

Constitutively Active Canonical NF-κB Pathway Induces Severe Bone Loss in Mice
por: Otero, Jesse E., et al.
Publicado: (2012)

Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia
por: XU, ZHEN-SHU, et al.
Publicado: (2015)

HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma
por: Malissen, Nausicaa, et al.
Publicado: (2019)

Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation
por: Guma, Monica, et al.
Publicado: (2011)

Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation
por: Guma, Monica, et al.
Publicado: (2012)

Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling
por: Jiang, Lili, et al.
Publicado: (2019)

Type Iγ phosphatidylinositol phosphate kinase regulates PD-L1 expression by activating NF-κB
por: Xue, Junli, et al.
Publicado: (2017)

GNG12 regulates PD‐L1 expression by activating NF‐κB signaling in pancreatic ductal adenocarcinoma
por: Li, Juan, et al.
Publicado: (2020)

NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis
por: Stansel, Tomoko, et al.
Publicado: (2020)

Inhibition of constitutive and cxc-chemokine-induced NF-κB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells
por: Seaton, A, et al.
Publicado: (2009)

Oncogenic B-RAF(V600E) signaling induces the T-box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion
por: Boyd, Suzanah C., et al.
Publicado: (2012)

Detection of carcinoembryonic-like antigen on melanoma cells by leucocyte-dependent-antibody assays.
por: Morgan, G., et al.
Publicado: (1977)

Cannot write session to /tmp/vufind_sessions/sess_pe1ncu7qincmrt224qb5cvr06e